Guidance for Organ Donation and Transplantation Professionals Regarding the Zika Virus
Published 4 February 2016
UNOS; Feb 2016.
Zika virus is a flavivirus transmitted by Aedes (Stegomyia) mosquitoes, most commonly by A. aegypti. Zika virus has been recognized in Brazil since 2014, and local transmission now has been reported in more than 20 countries and territories in the Western Hemisphere, including South America, Central America, Mexico, and the Caribbean.
The OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee (DTAC), the American Society of Transplantation (AST), and the American Society of Transplant Surgeons (ASTS), after careful review of information available from the Centers for Disease Control and Prevention (CDC), offers this information to transplant centers and Organ Procurement Organizations (OPOs) in light of recent spread of Zika virus throughout large parts of the Americas.
Read at UNOSRelated Guidlines
-
HFSA/SAEM/ISHLT Clinical Expert Consensus Document on the Emergency Management of Patients with Ventricular Assist Devices
-
Donor Heart and Lung Procurement: A Consensus Statement
-
ISHLT Consensus Statement on Donor Organ Acceptability and Management in Pediatric Heart Transplantation
-
ISHLT Advisory Statement on the Implications of Pandemic Influenza for Thoracic Organ Transplantation
-
A 2010 Working Formulation for the Standardization of Definitions of Infections in Cardiothoracic Transplant Recipients